EVISA Print | Glossary on | Contact EVISA | Sitemap | Home   
 Advanced search
The establishment of EVISA is funded by the EU through the Fifth Framework Programme (G7RT- CT- 2002- 05112).

Supporters of EVISA includes:

OSHA Issues Hexavalent Chromium Guidance for Small Businesses


The guide describes the steps that employers are required to take to protect employees from hazards associated with exposure to Cr(VI). It is divided into sections that address the major provisions of the standards, and follows the same organization as the corresponding paragraph of the standards.

To help employers better understand the requirements, the guide provides more detail than the standards, according to OSHA.

Among the major topics covered in the guide are:

  • Permissible exposure limits (PEL);
  • Exposure determination;
  • Regulated areas;
  • Methods of compliance;
  • Respiratory protection;
  • Protective work clothing and equipment,
  • Hygiene areas and practices,
  • Housekeeping; and
  • Medical surveillance.

Hexavalent chromium compounds are widely used in the chemical industry as ingredients and catalysts in pigments, metal plating and chemical synthesis. Cr(VI) also can be produced when welding on stainless steel or Cr(VI)-painted surfaces.

The major health effects associated with exposure to Cr(VI) include lung cancer, nasal septum ulcerations and perforations, skin ulcerations and allergic and irritant contact dermatitis.

"This new resource is aimed at helping small businesses comply with the new standards, while helping them reduce the risk to employees potentially exposed to these compounds," OSHA Administrator Edwin Foulke Jr. said.

The guide is available in the PDF-format on OSHA's Web site.

Related EVISA News

February 28, 2006: OSHA Issues Final Standard on Hexavalent Chromium

April 12, 2007: OSHA Agrees to Monitor Worker Exposure to Hexavalent Chromium-Containing Cement

last time modified: June 22, 2020


Imprint     Disclaimer

© 2003 - 2024 by European Virtual Institute for Speciation Analysis ( EVISA )